Louise Sigfrid
Overview
Explore the profile of Louise Sigfrid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
4239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antonio E, Pulik N, Ibrahim S, Adenipekun A, Levanita S, Foster I, et al.
BMC Med
. 2025 Mar;
23(1):147.
PMID: 40059172
Background: Priority setting for research on epidemic/pandemic-prone pathogens is essential for the allocation of limited resources to optimise impact. It involves the identification of gaps in knowledge crucial to effective...
2.
Kabajaasi O, Schilling S, Akugizibwe M, Horby P, Hart P, Sigfrid L, et al.
BMJ Public Health
. 2025 Feb;
3(1):e001165.
PMID: 40017927
Introduction: Prior research highlighting the complexity of clinical management guidelines' (CMGs) implementation during high consequence infectious disease (HCID) outbreaks has suggested that limited access to treatments and equipment and substantial...
3.
Kasbergen L, de Bruin E, Chandler F, Sigfrid L, Chan X, Hookham L, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39987930
Background: Arboviruses are increasingly affecting Europe, partly due to the effects of climate change. This increase in range and impact emphasises the need to improve preparedness for emerging arboviral infections...
4.
Sigfrid L, Chan X, Kasbergen L, Hookham L, Wei J, Chen S, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39987929
Background: Arboviruses have expanded into new regions in Europe, yet data indicate gaps in disease notifications and a risk of further spread. We aimed to report on prevalence, clinical management,...
5.
Pazukhina E, Garcia-Gallo E, Reyes L, Kildal A, Jassat W, Dryden M, et al.
BMJ Glob Health
. 2024 Oct;
9(10).
PMID: 39433402
Introduction: A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to...
6.
Azambuja P, Bastos L, Batista-da-Silva A, Ramos G, Kurtz P, Dias C, et al.
Lancet Reg Health Am
. 2024 Aug;
37:100839.
PMID: 39100241
Background: Long COVID is an emerging global public health issue. Socially vulnerable communities in low- and-middle-income countries were severely impacted by the pandemic and are underrepresented in research. This prospective...
7.
Menkir T, Citarella B, Sigfrid L, Doshi Y, Reyes L, Calvache J, et al.
medRxiv
. 2024 Jul;
PMID: 39040190
Importance: Post-acute sequelae of SARS-CoV-2, referred to as "long COVID", are a globally pervasive threat. While their many clinical determinants are commonly considered, their plausible social correlates are often overlooked....
8.
Norton A, Sigfrid L, Antonio E, Bucher A, Ndwandwe D
Lancet
. 2024 Mar;
403(10433):1233.
PMID: 38518795
No abstract available.
9.
Cho S, Premraj L, Battaglini D, Fanning J, Suen J, Li Bassi G, et al.
Brain Commun
. 2024 Mar;
6(2):fcae036.
PMID: 38444907
Although it is known that coronavirus disease 2019 can present with a range of neurological manifestations and in-hospital complications, sparse data exist on whether these initial neurological symptoms of coronavirus...
10.
Paterson A, Cheyne A, Jones B, Schilling S, Sigfrid L, Stolow J, et al.
Emerg Infect Dis
. 2024 Feb;
30(3):519-529.
PMID: 38407230
Infectious disease outbreaks are associated with substantial stigma, which can have negative effects on affected persons and communities and on outbreak control. Thus, measuring stigma in a standardized and validated...